Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer02:18

Cancer

51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

7.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Click Capture SELEX for the Identification of Click-Modified Aptamers Targeting Small Molecules in Solution.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Selection and Characterization of SARS-CoV-2 Spike Binding Clickmers.

Chembiochem : a European journal of chemical biology·2026
Same author

Lighting the spark of aptamer data science.

Science (New York, N.Y.)·2026
Same author

Exploring an Aptamer-Based Approach to Assess Canine Parvovirus Integrity After Disinfection Treatment.

Viruses·2025
Same author

Robotic-Assisted Capture-Systematic Evolution of Ligands by Exponential Enrichment of RNA Aptamers Binding to Small Molecules.

Chembiochem : a European journal of chemical biology·2025
Same author

Anti-gene oligonucleotides targeting Friedreich's ataxia expanded GAA⋅TTC repeats increase Frataxin expression.

Molecular therapy. Nucleic acids·2025

Related Experiment Video

Updated: May 3, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.8K

Multifunctional nucleic acids for tumor cell treatment.

Monika Pofahl1, Jesper Wengel, Günter Mayer

  • 11 Life and Medical Sciences Institute, University of Bonn , Bonn, Germany .

Nucleic Acid Therapeutics
|February 6, 2014
PubMed
Summary

Researchers developed AptamiR, a novel nucleic acid molecule for targeted cancer therapy. This single molecule delivers antimiR to silence microRNA, inhibiting cancer growth and restoring gene expression.

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.2K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Related Experiment Videos

Last Updated: May 3, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.8K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.2K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • MicroRNAs (miRNAs) play crucial roles in cellular processes, and their dysregulation, particularly by oncomiRs, is implicated in cancer development.
  • Targeted delivery of therapeutic nucleic acids like anti-miRs is a promising strategy for cancer treatment.
  • Existing approaches often face challenges in achieving cell-specific delivery and maintaining multiple functionalities.

Purpose of the Study:

  • To design and characterize a multifunctional nucleic acid molecule, AptamiR, for targeted cancer therapy.
  • To evaluate the cell-specific delivery, anti-proliferative effects, and miRNA silencing capabilities of AptamiR.
  • To assess the potential of AptamiR in restoring gene expression silenced by oncomiRs and inhibiting cancer cell growth.

Main Methods:

  • AptamiR was engineered by conjugating an aptamer domain for cell targeting with an anti-miRNA (antimiR) domain for gene silencing.
  • The functional integrity of AptamiR, including cell targeting, anti-proliferative activity, and antimiR function, was assessed in vitro.
  • The impact of AptamiR on endogenous miRNA levels, target gene expression, and cancer cell growth was evaluated in relevant cancer models.

Main Results:

  • AptamiR, a 37-nucleotide molecule, successfully integrated aptamer and antimiR functionalities.
  • The engineered AptamiR demonstrated cell-specific delivery and retained its anti-proliferative and antimiR functions.
  • AptamiR effectively inhibited cancer cell growth and induced the expression of genes pathologically suppressed by oncomiRs.

Conclusions:

  • AptamiR represents a novel, multifunctional nucleic acid platform for targeted cancer therapy.
  • This single-molecule approach offers efficient delivery of antimiRs for miRNA silencing and cancer treatment.
  • The findings suggest significant potential for AptamiR in future aptamer- and antimiR-based tumor targeting and therapeutic strategies.